2,6-dichloro-alpha-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)benzeneacetonitrile,
Clinacox,
diclazuril,
R 64433,
R-64433,
DICLAZURIL,
101831-37-2,
Clinacox,
Vecoxan,
2-(4-chlorophenyl)-2-[2,6-dichloro-4-(3,5-dioxo-1,2,4-triazin-2-yl)phenyl]acetonitrile,
NCGC00168785-01,
R-64433,
Diclazurilo,
Diclazurilum,
2,6-Dichloro-alpha-(4-chlorophenyl)-4-[4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl]benzeneacetonitrile,
2-(4-chlorophenyl)-2-(2,6-dichloro-4-(3,5-dioxo-4,5-dihydro-1,2,4-triazin-2(3H)-yl)phenyl)acetonitrile,
SR-05000001484,
Nuoqiu,
Diclazuril [USAN:USP:INN:BAN],
(4-chlorophenyl)[2,6-dichloro-4-(3,5-dioxo-4,5-dihydro-1,2,4-triazin-2(3H)-yl)phenyl]acetonitrile,
2,6-dichloro-alpha-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)benzeneacetonitrile,
AC1L9UTR,
Diclazuril (USAN/INN),
DSSTox_CID_26787,
DSSTox_RID_81905,
DSSTox_GSID_46787,
SCHEMBL126138,
CHEMBL284733,
DTXSID4046787,
CHEBI:95118,
ZSZFUDFOPOMEET-UHFFFAOYSA-N,
HMS2089N18,
HMS3655D11,
HMS3715D21,
Pharmakon1600-01502348,
BCP12257,
HY-B0357,
Tox21_112645,
BBL005225,
BDBM50088493,
GP6995,
NSC759642,
STL135982,
AKOS005746928,
CCG-213044,
CS-2411,
KS-5064,
MCULE-4598187571,
NSC-759642,
SB18820,
NCGC00168785-02,
AC-12108,
AN-34253,
BC204051,
CC-26555,
SC-13717,
AB0105674,
AB2000434,
CAS-101831-37-2,
D5457,
FT-0603078,
SW199606-2,
D03794,
Diclazuril, VETRANAL(TM), analytical standard,
AB01562968_01,
AB01562968_02,
831D372,
A800467,
C-21857,
P 64433,
I01-0373,
J-000501,
SR-05000001484-1,
SR-05000001484-2,
Diclazuril, United States Pharmacopeia (USP) Reference Standard,
2-[4-(4-chloro-alpha-cyanobenzyl)-3,5-dichlorophenyl]-1,2,4-triazine-3,5(2H,4H)-dione,
Diclazuril for system suitability, European Pharmacopoeia (EP) Reference Standard,
2,6-Dichloro-.alpha.-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)benzeneacetonitrile,
2,6-Dichloro-|A-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile,
2,6-Dichloro-|A-(4-chlorophenyl)-4-[4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl]benzeneacetonitrile,
2,6-dichloro-alpha-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile,
2,6-dichloro-alpha-(4-chlorophenyl)-4-[4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3h)-yl]benzeneacetonitr,
2-[4-[3,5-bis(oxidanylidene)-1,2,4-triazin-2-yl]-2,6-bis(chloranyl)phenyl]-2-(4-chlorophenyl)ethanenitrile,
null,
Coxiril,
DCZL,
Diclazurilum [Latin],
Diclazurilo [Spanish],
UNII-K110K1B1VE,
C17H9Cl3N4O2,
Diclazuril [USAN:BAN:INN],
Diclazuril [USAN:INN:BAN],
K110K1B1VE,
DRG-0079,
C17-H9-Cl3-N4-O2,
CID456389,
DL-164,
s2028,
CS-O-01281,
Diclazuril, 98% - 100MG 100mg,
R64,433,
R 64433,
(p-Chlorophenyl)(2,6-dichloro-4-(4,5-dihydro-3,5-dioxo-as-triazin-2(3H)-yl)phenyl)acetonitrile,
DCL,
(p-chlorophenyl)[2,6-dichloro-4-(4,5-dihydro-3,5-dioxo-as-triazin-2(3H)-yl)phenyl]acetonitrile,
2,6-Dichloro-alpha-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)benz-eneacetonitrile,
Benzeneacetonitrile, 2,6-dichloro-alpha-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-,